Abstract
Until now, a few studies have been conducted on the destructive effects of TiO2 NPs in living organisms, and studies on the toxicity of TiO2 NPs are still in the beginning phases. Because of the widespread use of TiO2 NPs in all areas of human life, it is essential to study their profound and fundamental toxic effects on each organ and body cell. Herein, we evaluate the effect of exposure to TiO2 NPs on in vitro models derived from the rat bone marrow and adipose tissues. Exposure to TiO2 NPs at 100 and 200 μg/ml exhibited cytotoxicity for the rat bone marrow mesenchymal stem cells (rBMSCs) and rat adipose mesenchymal stem cells (rATSC), respectively. Additionally, reduced rBMSCs and rATSCs frequencies in the S phase of the cell cycle. Moreover, TiO2 NPs enhanced the activity of cellular senescence-associated β-galactosidase in both model cells. Significantly higher relative expression of aging-related genes P53 and NF-kB (p < 0.05) and lower expression levels of anti-aging-related genes Nanog and SIRT1 were found in the treated cells (p < 0.05). Colony-forming and DAPI staining showed the reduction of cell growth and DNA damage in both rBMSCs and rATSCs. Our findings along with other similar findings showed that TiO2 NPs probably have negative effects on the cell growth, prompt the cells for entry into proliferation stop, DNA damage, and trigger the aging process.
Introduction
The advancements in nanotechnology and nanoscience during the last decades revealed innovative and attractive engineered nanoparticles (ENPs) with specific properties in a wide range of areas. In consequence, human beings are intentionally or unintentionally exposed to those ENPs during their lifetime, which leads to increasing concerns in regards to their probable toxicity in human health [1, 2]. On the other hand, due to the unique properties of nano-sized particles they represent more toxicity in comparison to the larger micron-sized particles [3].
Among the existing nanomaterials [4], titanium dioxide nanoparticles (TiO2 NPs) are widely used for consumable and industrial applications including coatings, papers, plastics, food products, medicines, pharmaceuticals, toothpaste, and cosmetics [5]. Brookite, anatase, and rutile are three polymorphic forms of TiO2 NPs. They indicate a strong refractive index for both UVA and UVB lights and have been universally accepted as a good UV filter [6]. They are prominent for their unique properties such as high stability, large surface area, anti-corrosive, and activities like food colorant and photocatalytic activity. As a result of these predominant properties, the production and application of TiO2 NPs are continually increased, leading to progressed human exposure to these nanoparticles.
One of the main problems associated with the application of ENPs such as TiO2 NPs is their ability to penetrate through the physiological barriers into the bloodstream and reach the organs such as the kidney, heart, liver, brain, spleen, and bone marrow ([7–10]). In those organs they can pass through the cell membrane and enter the mitochondria, causing organelle dysfunctions [11]. The result of in vitro and in vivo studies demonstrated that the probable toxicity of TiO2 NPs could include mitochondrial dysfunction, decretion in cell viability, and generation of oxidative stress causing genotoxicity and apoptosis [12, 13].
The most common way to assess the toxicity of nanoparticles is by investigating their effects on the proliferation of cells. Stem cells are the famous category of proliferative cells. They are positioned in specific niches of a variety of organs and remain quiescent until they receive some signals which activate them to start differentiation or repair [14]. These cells are susceptible to the influence of the particles that enter the cell and even remain in their immediate environment. To prove this fact, we used Mesenchymal stem cells (MSCs) and TiO2 NPs in anatase form.
MSCs were used in toxicology research for the first time in1982 [15]. Subsequently, technologies on the stem cell have been directed to various novel developments in toxicity testing [16, 17]. Scanu et al. indicated that human MSCs provided more perfectible in vivo modeling for toxicology research [18]. Therefore, we designed this study to assess the effect of TiO2 anatase NPs on stem cells derived from rat bone marrow (rBM) and adipose tissue. Here, we evaluated the effects of TiO2NPs on the proliferation, viability, and differentiation potential of human Wharton’s jelly MSCs. Also, the viability, proliferation, cell cycle, apoptosis, senescence gene markers, colony forming, and stemness gene expression in rat bone marrow (rBMSCs) and adipose tissue-originated (rATSCs) cells exposed to TiO2 anatase were evaluated. Our work indicated that TiO2 NPs could affect both in vitro model cells and prompted cells to reduction of proliferation, colony forming, stemness properties, aging, and apoptosis.
Material and methods
Properties of TiO2 nanoparticles and preparing the stock solution
Titanium dioxide nanoparticles with 99.5% purity were purchased from Sigma-Aldrich, USA. To prepare 1 mg/ml stock solution, 10 mg of NPs was completely dispersed in the 10 ml routine culture medium. The solution was sterilized by autoclaving and put in the fridge until needed. Then different aliquots (50, 70, 130, 150, 170, 200, 240, and 280 µg/ml) were prepared for the cell culture.
Field emission scanning electron microscopy (FESEM)
Morphological characterization of the TiO2 nanoparticles was studied by field emission scanning electron microscope (Fesem Quantum 200 fei, USA). The samples were prepared by adding TiO2 nanoparticles to the propanol (Sigma-Aldrich Co., Ltd.), then suspended using prob type sonicator, and were allowed to dry.
Dynamic light scattering (DLS)
The particles size distribution of TiO2 nanoparticles in the aqueous phase and 25 °C was determined by the DLS technique (Zetasizer Nano ZS90; Malvern Instruments, UK). The samples were prepared at the concentration of 0.1% wt.
Isolation of MSCs from rat bone marrow or adipose tissue
MSCs were isolated from rBM as previously described by Eslaminejad et al. [19]. Surgery on rats was performed according to ethical considerations by a veterinarian. As a brief protocol, the mice were euthanized in CO2 chambers, and two bone types, including tibias and femurs, were dissected. Then, their marrow bones were gently flushed in DMEM (Invitrogen, USA) and supplemented with 10% fetal bovine serum (FBS, Gibco, Germany), 100 U/ml penicillin (Sigma, Germany), and 100 mg/ml streptomycin. The MSCs were isolated by Ficol centrifugation, transferred into a 25-cm2 culture vessel, and incubated in an incubator with a standard 37 °C humidified atmosphere containing 5% CO2 for 14 days [19]. The extraction of adipose MSCs was conducted as described by Alizadeh et al. [20], with some modifications. Briefly, the subcutaneous adipose tissue was dissected from mice and then minced into tiny fragments. After a while, it was digested with collagenase type I. Then, mononuclear cells, including stromal vascular fraction, were separated using Ficoll (Bioidea, Iran). After that, a mesh filter was used to remove the unwanted cells, and then the RBC lysis buffer was employed to eradicate the residual RBCs. Finally, the extract was transferred to the DMEM culture medium (Gibco, Invitrogen) containing 10% FBS (Gibco, Invitrogen), 1X ITS (Sigma, USA), dexamethasone 1 × 10−6 M, and 1% penicillin/streptomycin (Gibco, Invitrogen). After 24 h incubation at 37 °C and 5% CO2, the non-adherent cells were removed, and later the medium was refreshed every 3 days until 70–80% confluency was achieved [21]. Osteogenic differentiation and mineralization of the cells were evaluated by alizarin red staining [22].
Flow cytometry analysis
The CD markers of rBMSCs and rATSCs were further characterized by flow cytometry. After washing with PBS, the cells were stained with FITC-conjugated anti-human CD90 and CD105 (MSC markers), also with CD45 and CD34 (as negative markers) [23]. The cells were then analyzed on a flow cytometer (DB FACS, Dickinson) using FACS CellQuest software for the expression of their surface markers.
In vitro cytotoxicity assessment
The cytotoxic effect of TiO2 NPs on rBMSCs and rATMCs was studied by the MTT (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) (Acros Organics Company) assay. Briefly, the cells were seeded into 96-well plates at a density of 2 × 104 cells/well. After 24 h of incubation at 37 °C, the culture medium was removed, and the cells were treated with different concentrations of TiO2 NPs (10–500 µg/ml) in triplicate for 1, 2, and 3 days. Also, untreated cells with 100% viability were used as a control. After completion of the incubation, the culture medium was replaced by a fresh medium containing 20 µl MTT solution (0.5 mg/ml in DMEM). Following 4 h of incubation at 37 °C, intracellular insoluble formazan was solubilized by adding 200 μl/well DMSO (Dimethyl sulfoxide), and absorbance value was measured at 570 nm against a blank reagent using a scanning spectrophotometer (AWARENESS, technology INC). The viability of cells was calculated according to the following formula:
Cell cycle assay
rBMSCs and rATSCs were cultured in 6-well plates at an initial cell seeding density of 5 × 105 cells/cm2. At confluency of 70%, the cells were treated with TiO2 NPs in concentration around their IC50 (100 and 200 µg/ml for rBMSCs and rATSCs, respectively). After 72 h, the cells were washed twice with PBS, then fixed with 70% ethanol and stored at 4 °C for 2 days. After collecting the fixed cells by centrifugation, they were washed twice with PBS and resuspended in PBS followed by treated with RNase A for 45 min. Subsequently, DNA intercalating dye propidium iodide solution (PI) (Sigma) was added to the suspension and incubated for 15 min in the dark. The samples were then analyzed by a flow cytometer to determine the percentage of fluorescent intensity. The cell progression in different phases of the cell cycle was evaluated through the DNA histogram by Becton-Dickinson FACS Calibur Flow Cytometer using CellQuest software (Becton-Dickinson, San Jose, CA, USA).
Apoptosis study by DAPI staining
To visualized the apoptotic effect of TiO2 nanoparticles toward rBMSCs and rATSCs, the nuclei of the cells were stained by DAPI (4′,6-diamidino-2-phenylindole) according to the following: the cells were seeded into 6-well plates at the density of 5 × 105 cells/well. After 24 h incubation at 37 °C, the culture medium was changed, and the cells were treated with TiO2 NPs in concentration around their IC50 (100 and 200 µg/ml for rBMSCs and rATSCs, respectively) for 48 h. Thereafter, the medium was removed, the cells were washed with PBS, and finally fixed with 4% paraformaldehyde for 10 min. The cell permeabilization was carried out by adding a permeabilization buffer (3% paraformaldehyde and 0.5% Triton X-100) and incubating for 15 min. Then the cells’ nuclei were stained with 1 µg/ml DAPI solution (Sigma, Germany). Finally, the cells were resuspended in PBS, and the morphology of the nuclei was assessed under fluorescence microscopy (Olympus IX81, Germany) at ×400 magnification. The condensed and fragmented nuclei were detected in the apoptotic cells.
Forming-colony assay
We directed colony-forming experiments according to our previously published article [24]. Briefly, rBMSCs or rATSCs in passage 3 were seeded at a density of 200 cells in 100-mm petri dishes in the standard DMEM/FBS medium for 1 day to let the cells adhere. The medium was then replaced by the medium containing TiO2 NPs (100 and 200 µg/ml for rBMSCs and rATSCs, respectively) or just the fresh medium in control groups. The colonies were then fixed with 2.5% glutaraldehyde for 20 min. The colonies were stained with 0.5% crystal violet solution for 30 min and finally rinsed with PBS. The colonies were counted using an inverted microscope (Olympus, Center Valley, PA, USA).
Real-time PCR
Forty-eight hours after treatment with TiO2 NPs in concentration around their IC50 (100 and 200 µg/ml for rBMSCs and rATSCs, respectively), total RNA was extracted from rBMSCs and rATSCs using an RNA extract kit (Bio Basic INC, USA). cDNA was synthesized using the PrimeScriptTM RT Kit (TaKaRa, Japan) and used for real-time PCR using SYBR® Premix Ex Taq™ I (TaKaRa, Japan) and a pair of specific primers for Nanog, P53, SIRT1, NFkb, RUNX2, Osteocalcin, OCT4, and SOX2 genes (Table 1). The real-time PCR reaction was performed in a thermal cycler (BioRad, USA). After initial denaturation at 95 °C for 3 min, amplification was carried out in 40 cycles at 95 °C for 20 s, 60 °C for 20 s, and 72 °C for the 30 s. Relative expression of the genes in each source of the cells was calculated related to the GAPDH housekeeping gene.
Table 1.
Gene | Primer name | Sequence | Length |
---|---|---|---|
Nanog | Forward | GAGACTGCCTCTCCTCCGCCTT | 22 |
Reverse | GTGCACACAACTGGGCCTGA | 20 | |
P53 | Forward | GTCGGCTCCGACTATACCACTATC | 24 |
Reverse | CTCTCTTTGCACTCCCTGGGG | 21 | |
GAPDH | Forward | TCAAGAAGGTGGTGAAGCAG | 20 |
Reverse | AGGTGGAAGAATGGGAGTTG | 20 | |
NF-KB | Forward | GTCGGCTCCGACTATACCACT | 21 |
Reverse | TCCTCTCTTTGCACTCCCTGGG | 22 | |
Sirt 1 | Forward | CGCCTTATCCTCTAGTTCCTGTG | 23 |
Reverse | CGGTCTGTCAGCATCATCTTCC | 22 |
In situ assay of β-galactosidase for cellular senescence
Senescence-associated β-galactosidase (SA-β-Gal) staining was conducted utilizing the SA-β-gal staining kit (Dimri, USA) according to the protocol of the manufacturer. Briefly, rBMSCs and rATSCs were cultured in 24-well plates. At the confluency of 80%, the cells were treated with TiO2 NPs in concentration around their IC50 (100 and 200 µg/ml for rBMSCs and rATSCs, respectively) for 72 h/min. Afterward, the cells were fixed using G/F fixative mix at room temperature for 3–5 min. The cells were washed twice with 1XPBS and stained with the staining solution X-gal at 37 °C for 2 h. The SA-β-gal-positive cells exhibited a green color. Positive cells were counted under an inverted light microscope.
Statistical analysis
All the experiments were performed in triplicate, and the results were shown as mean ± standard deviation. The experimental data were analyzed by SPSS (IBM Corp. NY, USA) using the two-way analysis of variance.
Results
Evaluation of TiO2 NPs size by DLS technique
The size distribution of the TiO2 NPs was determined by DLS. The results are shown in Fig. 1. To assess the particle size, NPs were redispersed ultrasonically using prob type sonicator (300w, 30 s). As shown in Fig. 1, the majority of NPs (98.05%) was 77.91 nm in size, and an ignorable ratio (about 1.95%) was 326.63 nm. Also, there was a slight increase between the size diameter resulting from the DLS and the primary structure of TiO2 NPs resulting from SEM, since in DLS the hydrodynamic diameter of the particles in the liquid is measured.
SEM images of TiOFE2NPs
Figure 2 shows the structure and morphology of the TiO2 NPs. As can be seen from the figures, they have an irregular rock-like structure with large variations in size ranging from a few nanometers to around 2.6 microns. The high magnification images of these particles revealed the nanocrystalline domain with an average size of about 56 nm. So, based on the previous works, which confirmed this type of image [25, 26], we can conclude that TiO2 NPs consist of a secondary structure with particle diameters around a few microns (Fig. 2E red cycle). And these secondary structures are formed by the agglomeration of the primary structures with particle diameters around a few tens of nanometers (Fig. 2E yellow cycle).
Characterization of rBMSCs and rATSCs
The rat mesenchymal stem cells were isolated from bone marrow and adipose tissue. rBMSCs and rATSCs showed the classic morphology of MSCs, spindle shape with the adherent phenotype (Fig. 3A, C). In initial subcultures, rBMSCs represented smaller cells (Fig. 3A), however, due to the passages giant cells that appeared in the culture, which are the signs of in vitro senescence, rATSCs were a little bigger or longer than rBMSCs, as depicted in Fig. 3C. Alizarin red staining showed the presence of mineralized particles in the stem cells, indicating the osteogenesis potential of the cells (Fig. 3B, D). The majority of rBMSCs or rATSCs (95–97.3%) showed the positive surface expression of CD90 as a surface marker in the MSCs. The rBMSCs and rATSCs were found to be 96.77% or 87.56% positive for CD105, respectively (Fig. 3E, F). Moreover, an ignorable percentage (<1%) of both cells showed the expression of CD34 and CD45 as hematopoietic lineage markers (Fig. 3E, F).
In vitro cytotoxicity evaluation of TiO2 NPs
MTT-based cytotoxicity test was employed to check the viability of stem cells after treatment with TiO2 (0–500 µg/ml) for 1, 2, and 3 days (Fig. 4). No obvious evidence of cytotoxicity was observed 1 and 2 days after treatment with different concentrations of TiO2 NPs, representing excellent cytocompatibility of the nanoparticles. Upon increasing the time of exposure to 3 days, cell viability was reduced. It showed that the viability of rBMSCs and rATSCs decreased in a time- and dose-dependent manner (Fig. 4).
TiO2 NPs induced cell cycle distribution in rBMSCs and rATSCs
Herein, cell cycle analysis was conducted to evaluate the cell cycle progression of rBMSCs and rATSCs under normal growth conditions and after being treated with NPs in concentration around their IC50 (100 and 200 µg/ml for rBMSCs and rATSCs, respectively). The calculation of the area under the peak was done by CellQuest software (Becton Dickinson, San Jose, CA, USA) to identify the phase within the cell cycle. The effect of TiO2 NPs on cell cycle distribution was studied by propidium iodide staining of the cell nucleus. The rBMSCs exposed to 100 µg/ml TiO2 NPs represented fewer cells in the S and G2/M phases when compared to the control group; the percentage of cells in the G0/G1 phase increased in comparison with the control group (Fig. 5). The population of cells in the S and G2/M phases reduced in the rATSCs treated with 200 µg/ml TiO2, while the percentage of cells entering the G0/G1 phase increased (82.11%) (Fig. 5).
Evaluation of apoptosis using DAPI staining
The morphological alteration induced by apoptosis in rBMSCs and rATSCs was studied by DAPI staining. In this regard, the density of nuclei and morphology of chromatin were observed under fluorescence microscopy after 48 h treatment by TiO2 NPs. The untreated rBMSCs and rATSCs (control group) showed normal nuclei (Fig. 6A, B), while the cells treated with TiO2 NPs represented the fragmentation of nuclei compared with untreated cells in both cells lines. In addition, the reduction in the density of the cells treated with TiO2 NPs is observed in comparison with the control groups indicating the engulfing of apoptotic cells through the neighboring cells or phagocytes by phagocytosis (Fig. 6C, D).
Colony-forming results
Treatment with TiO2decreased the colony-forming unit efficiency, as evidenced by the reduced number and size of colonies from both rBMSCs and rATSCs compared to the control group (Fig. 7).
Gene expression analysis
The relative expression of P53 and NF-kB as aging-relevant genes was evaluated 48 h after treatment with 100 and 200 µg/ml TiO2NPs for rBMSCs and rATSCs, respectively. A significant up-regulation of the NF-kB gene was observed at the concentration of 200 µg/ml (p ≤ 0.001) compared to other groups (Fig. 8A, B). However, there was a significant (p ≤ 0.05) up-regulation in both rBMSCs and rATSCs at 100 µg/ml in comparison with the control group (Fig. 9A, B). As shown in Fig. 8, a significantly higher expression of P53 (p ≤ 0.0001) was found in both rBMSCs and rATSCs after treatment with 100 µg/ml TiO2 NPs compared to other groups. When compared to the control group, a significant up-regulation (p ≤ 0.001) was also detected at 200 µg/ml concentration (Fig. 8).
Relative expression of Sirt1 and Nanog as anti-aging genes was also measured. The results showed significant down-regulation of the Nanog gene in both rBMSCs and rATSCs compared to control groups at both 100 and 200 µg/ml concentrations (p ≤ 0.0001) (Fig. 8). Significant down-regulation (p ≤ 0.001) was also observed in the expression of the Sirt1 gene in comparison with the controls (Fig. 8).
β-galactosidase in situ assay
Beta-galactosidase enzyme activity was measured to assess the effect of TiO2 NPs on the senescence of MSCs. The results, depicted in Fig. 9 represented a higher β-galactosidase activity (the TiO2-treated cells with positive green staining of cell areas compared to the controls).
Discussion
One of the main issues in nanotechnology and nanoscience is the more toxicity of nanoparticles in comparison with the large-sized particles, as a result of their extensive surface area and enhanced cellular uptake [27]. Due to the wide application of TiO2 NPs, the exposure of human beings to these nanoparticles is going to be increased. As a result, the TiO2 NPs have been widely studied regarding their potential toxicity to human health.
The present study evaluated the potential toxicity of different concentrations of TiO2 nanoparticles on rat-derived stem cells. The results indicated that TiO2 NPs cause toxic effects on the growth, clonogenicity, stemness, cell cycle, DNA fragmentation, and apoptosis of rBMSCs and rATSCs.
In this study, we used bone marrow and adipose tissue derived from rats as model cells due to the potential application of the MSCs, especially from bone marrow, in the toxicity study that was evidenced in another study [18]. After isolation of model cells, both rATSCs and rBMSCs were studied to confirm the characteristics of MSCs, surface CD markers, osteogenic differentiation, and morphological phenotype.
TiO2 NPs were also characterized in terms of size and morphology utilizing DLS and SEM, respectively. As shown in the results section, the particles are irregular rock-like structures with large variations in size ranging from a few nanometers to around 2.6 microns. The colorimetric assay indicated a decline in proliferation, colony-forming, and cytotoxic properties. Generally, the cytotoxicity of nanostructured materials is dependent on the NPs concentration, type and structure, time of exposure, method of interaction with cells, and so on [28]. Our results are in line with those observed by Ghanbary et al. on the cytotoxicity of TiO2 nanoparticles in human monocytes [29]. The cytotoxic effect of TiO2 NPs on monocytes is proved to be related to intracellular ROS generation, collisions of mitochondrial membrane potential, lipid peroxidation, glutathione depletion, and lysosomal membrane damage [29, 30].
The in situ assay of β-galactosidase revealed cellular SA-β-Gal enzyme activity in the cells treated with 100 and 200 µg/ml of TiO2 NPs in both rBMSCs and rATSCs. In addition, extreme up-regulation of P53 and NF-kB genes was observed in those cells. P53 is regulated directly or indirectly via PKB/AKT kinase as the main factor of insulin/insulin-like growth factor (IGF)-1 signaling (IIS). Signaling of PKB/AKT is also pro-aging by NF-kB transcription factor [31, 32]. The NF-kB motioning pathway is suggested as another important aging mediator. This pathway is triggered by oxidative stress, genotoxicity, regulation of cytokine expression, inflammatory stress, regulating apoptosis genes, growth factors, cell senescence, cell cycle progression, and inflammation. NF-kB transcriptional activity is enhanced with aging in many of the tissues. NF-kB is related to various age-linked degenerative diseases such as osteoporosis, Alzheimer’s disease, and diabetes. NF-kB is a general responder to a wide range of stress stimulation and plays a main role in aging. NF-kB is directly involved in the aging process [33, 34]. Therefore, the increased activity of both p53 and subsequently NF-kB is related to the aging-inducing effect of TiO2. It is in agreement with the results of the present study on P53 and NF-kB as promoting aging factors [32, 35]. Moreover, down-regulation of anti-aging-related genes, as well as Nanog and Sirt-1, was detected in the stem cells treated with (200 µg/ml) of TiO2 NPs. Nanog prevents the aging effects on the proliferation of MSC and is noticeably up-regulated in DNA damage repair, DNA replication, and cell cycle [36]. In the previous studies, Nanog has been shown to enhance somatic and stem cell proliferation and self-renewal by regulating cell cycle, stemness, and senescence pathways [37]. Nanog is a homeodomain of transcription factor which not only has the potential to postpone aging but also can reverse aging [36, 38, 39]. There has been scientific evidence that Sirt1 activation disorders are associated with the onset of aging. Sirt1 has been shown to have a role in nutrient homeostasis and energy maintenance, thereby exerting its anti-aging effect due to its role in body metabolism [40, 41]. The main role of sirtuin proteins in promoting stress resistance and survival, which leads to longevity [42]. Recently, the anti-aging effects of caloric restriction have been simplified, and Sirt1 has been recognized as a caloric restriction-associated anti-aging molecule [42].
TiO2 NPs enter the body via many routes, causing toxicity via deposition in different organs and induction of cell apoptosis They also change the expression of hormones and damage the body organs [43]. In addition, TiO2 NPs becomes a substance to generate reactive oxygen species (ROS) intermediates in the biological systems because it is highly photoreactive [44]. ROS intermediates have harmful effects on cell viability and functions and subsequently stimulate innate immune responses, which results in inflammation and genotoxicity [45].
There are different studies on the suppression effect of TiO2 NPs on the cell cycle progression of various cell types [46]. Hou et al. investigated the effect of the highest concentrations of TiO2 on different phases of the mouse MSCs cycle (S, G1, G2). They represented a reduction in the number of cells in the S and G2 phases [47]. According to our cell cycle assay, TiO2 NPs induce apoptosis and inhibit the cell cycle, entering the syncretization phase (S) of a cell cycle. In cosmetic products, TiO2 nanoparticles are found as oil-in-water emulsions, which can easily penetrate the skin [48] and exhibit their negative effects.
DAPI staining of rATSCs and rBMSCs represented the degradation, fragmentation, and decrease in the density of the nuclei of the cells treated with TiO2 NPs. Based on our results, TiO2 NPs can also enter the nucleus and damage DNA directly or indirectly via alterations in gene expression [49]. Wamer et al. depicted that, the treatment of human skin fibroblasts with TiO2 NPs causes damages to the RNA and DNAs. According to their thesis, damaged RNA indirectly affects gene expression [50]. The pathological examination of the effects of TiO2 NPs in the liver and kidney has revealed that they are deposited and cause necrosis, cell apoptosis, and fibrosis in the liver, and glomerular swelling in the kidney [9, 48, 50, 51].
Conclusion
In this study, the effect of TiO2 NPs on both rat MSCs from bone marrow and adipose tissues was explored. The nanoparticles were studied in terms of morphology and size. The results represented that they are irregular rock-like structures with large variations in size ranging from a few nanometers to around 2.6 microns. Until now, a few studies have been conducted on the destructive effects of TiO2 NPs in living organisms, and studies on the toxicity of TiO2 NPs are still in the beginning phases. Because of the widespread use of TiO2 NPs in all areas of human life, it is essential to study their profound and fundamental toxic effects on each organ and body cell. Based on the results obtained from the MTT assay, TiO2 NPs showed cytotoxicity in both rBMSCs and rATSCs in a time- and dose-dependent manner. Also, the DAPI staining study and cell cycle analysis represented the induction of apoptosis in both cell types. Furthermore, constant exposure of tissues and organs to TiO2 NPs may lead to the accumulation of these particles. This accumulation results in the reduced capacity of MSCs for growth, colony formation, and triggers cellular damage and senescence. Such findings should be considered when using massive doses and long time consuming of TiO2 NPs. Considering the aforementioned results and taking into account the frequent exposure of human beings with TiO2 NPs, we can conclude their adverse effect on human health.
Acknowledgments
Funding
The authors would like to thank Deputy for Research and technology, Tabriz University of Medical Sciences for financial support of grant number (95/2-3/6).
Compliance with ethical standards
Conflict of interest
The authors declare no competing interests.
Ethical approval
Ethics code: IR.TBZMED.REC.1395.867.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Manizheh Sarikhani, Sevil Vaghefi Moghaddam
References
- 1.Meng H, Xia T, George S, Nel AE. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano. 2009;3:1620–7. doi: 10.1021/nn9005973. [DOI] [PubMed] [Google Scholar]
- 2.Sun TY, Bornhöft NA, Hungerbühler K, Nowack B. Dynamic probabilistic modeling of environmental emissions of engineered nanomaterials. Environ Sci Technol. 2016;50:4701–11. doi: 10.1021/acs.est.5b05828. [DOI] [PubMed] [Google Scholar]
- 3.Kocbek P, Teskač K, Kreft ME, Kristl J. Toxicological aspects of long‐term treatment of keratinocytes with ZnO and TiO2 nanoparticles. Small. 2010;6:1908–17. doi: 10.1002/smll.201000032. [DOI] [PubMed] [Google Scholar]
- 4.Djurišić AB, Leung YH, Ng AM, Xu XY, Lee PK, Degger N, et al. Toxicity of metal oxide nanoparticles: mechanisms, characterization, and avoiding experimental artefacts. Small. 2015;11:26–44. doi: 10.1002/smll.201303947. [DOI] [PubMed] [Google Scholar]
- 5.Awasthi A, Dube A, Kumari Y, Jangir LK, Awasthi KK, Awasthi K. Toxicological evaluation of TiO2 nanoparticles in bacterial cell. Paper presented at the Macromolecular Symposia. 2015.
- 6.Gilbert E, Pirot F, Bertholle V, Roussel L, Falson F, Padois K. Commonly used UV filter toxicity on biological functions: review of last decade studies. Int J Cosmet Sci. 2013;35:208–19. doi: 10.1111/ics.12030. [DOI] [PubMed] [Google Scholar]
- 7.Chen I-C, Hsiao I-L, Lin H-C, Wu C-H, Chuang C-Y, Huang Y-J. Influence of silver and titanium dioxide nanoparticles on in vitro blood-brain barrier permeability. Environ Toxicol Pharmacol. 2016;47:108–18. doi: 10.1016/j.etap.2016.09.009. [DOI] [PubMed] [Google Scholar]
- 8.Golasik M, Herman M, Olbert M, Librowski T, Szklarzewicz J, Piekoszewski W. Toxicokinetics and tissue distribution of titanium in ionic form after intravenous and oral administration. Toxicol Lett. 2016;247:56–61. doi: 10.1016/j.toxlet.2016.02.009. [DOI] [PubMed] [Google Scholar]
- 9.Li Y, Yan J, Ding W, Chen Y, Pack LM, Chen T. Genotoxicity and gene expression analyses of liver and lung tissues of mice treated with titanium dioxide nanoparticles. Mutagenesis. 2017;32:33–46. doi: 10.1093/mutage/gew065. [DOI] [PubMed] [Google Scholar]
- 10.Pujalte I, Dieme D, Haddad S, Serventi AM, Bouchard M. Toxicokinetics of titanium dioxide (TiO2) nanoparticles after inhalation in rats. Toxicol Lett. 2017;265:77–85. doi: 10.1016/j.toxlet.2016.11.014. [DOI] [PubMed] [Google Scholar]
- 11.Teodoro JS, Simões AM, Duarte FV, Rolo AP, Murdoch RC, Hussain SM, et al. Assessment of the toxicity of silver nanoparticles in vitro: a mitochondrial perspective. Toxicol Vitr. 2011;25:664–70. doi: 10.1016/j.tiv.2011.01.004. [DOI] [PubMed] [Google Scholar]
- 12.Freyre-Fonseca V, Delgado-Buenrostro NL, Gutiérrez-Cirlos EB, Calderón-Torres CM, Cabellos-Avelar T, Sánchez-Pérez Y, et al. Titanium dioxide nanoparticles impair lung mitochondrial function. Toxicol Lett. 2011;202:111–9. doi: 10.1016/j.toxlet.2011.01.025. [DOI] [PubMed] [Google Scholar]
- 13.Iavicoli I, Leso V, Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vivo studies. J Nanomater. 2012;5:1–36. [PubMed] [Google Scholar]
- 14.Adriana-Berenice P-V, Alberto P-B, María del Pilar R-G, Rebeca L-M, José A-G, Gutiérrez-Iglesias G, et al. Toxic effect of titanium dioxide nanoparticles on human mesenchymal stem cells. Mol Cell Toxicol. 2020;16:321–30. 10.1007/s13273-020-00084-8.
- 15.Pratt RM, Grove RI, Willis WD. Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate. Teratog Carcinog Mutagen. 1982;2:313–8. doi: 10.1002/1520-6866(1990)2:3/4<313::AID-TCM1770020312>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
- 16.Liang S, Liang S, Yin N, Faiola F. Establishment of a human embryonic stem cell-based liver differentiation model for hepatotoxicity evaluations. Ecotoxicol Environ Saf. 2019;174:353–62. doi: 10.1016/j.ecoenv.2019.02.091. [DOI] [PubMed] [Google Scholar]
- 17.Yin N, Liang X, Liang S, Liang S, Yang R, Hu B, et al. Embryonic stem cell-and transcriptomics-based in vitro analyses reveal that bisphenols A, F and S have similar and very complex potential developmental toxicities. Ecotoxicol Environ Saf. 2019;176:330–8. doi: 10.1016/j.ecoenv.2019.03.115. [DOI] [PubMed] [Google Scholar]
- 18.Scanu M, Mancuso L, Cao G. Evaluation of the use of human mesenchymal stem cells for acute toxicity tests. Toxicol Vitr. 2011;25:1989–95. doi: 10.1016/j.tiv.2011.07.006. [DOI] [PubMed] [Google Scholar]
- 19.Eslaminejad MB, Nikmahzar A, Taghiyar L, Nadri S, Massumi M. Murine mesenchymal stem cells isolated by low density primary culture system. Dev Growth Differ. 2006;48:361–70. doi: 10.1111/j.1440-169X.2006.00874.x. [DOI] [PubMed] [Google Scholar]
- 20.Alizadeh E, Nosratollah Z, Eslaminejad MB, Akbarzadeh A, Barzegar A, Mohammadi SA. The effect of dimethyl sulfoxide on hepatic differentiation of mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 2016;44:157–64. doi: 10.3109/21691401.2014.928778. [DOI] [PubMed] [Google Scholar]
- 21.Shotorbani BB, André H, Barzegar A, Zarghami N, Salehi R, Alizadeh E. Cell sheet biofabrication by co-administration of mesenchymal stem cells secretome and vitamin C on thermoresponsive polymer. J Mater Sci: Mater Med. 2018;29:170. doi: 10.1007/s10856-018-6180-z. [DOI] [PubMed] [Google Scholar]
- 22.Asghari F, Salehi R, Agazadeh M, Alizadeh E, Adibkia K, Samiei M, et al. The odontogenic differentiation of human dental pulp stem cells on hydroxyapatite-coated biodegradable nanofibrous scaffolds. Int J Polymeric Mater Polymeric Biomater. 2016;65:720–8. doi: 10.1080/00914037.2016.1163564. [DOI] [Google Scholar]
- 23.Nejati-Koshki K, Pilehvar-Soltanahmadi Y, Alizadeh E, Ebrahimi-Kalan A, Mortazavi Y, Zarghami N. Development of Emu oil-loaded PCL/collagen bioactive nanofibers for proliferation and stemness preservation of human adipose-derived stem cells: possible application in regenerative medicine. Drug Dev Ind Pharm. 2017;43:1978–88. doi: 10.1080/03639045.2017.1357731. [DOI] [PubMed] [Google Scholar]
- 24.Arezoumand KS, Alizadeh E, Esmaeillou M, Ghasemi M, Alipour S, Pilehvar-Soltanahmadi Y, et al. The emu oil emulsified in egg lecithin and butylated hydroxytoluene enhanced the proliferation, stemness gene expression, and in vitro wound healing of adipose-derived stem cells. Vitr Cell Dev Biol Anim. 2018;54:205–16. doi: 10.1007/s11626-018-0228-8. [DOI] [PubMed] [Google Scholar]
- 25.Wu X, Liu Y. Microstructure of metatitanic acid and its transformation to rutile titanium dioxide. High Temp Mater Process. 2020;39:627–32. doi: 10.1515/htmp-2020-0097. [DOI] [Google Scholar]
- 26.Zhang W, Ou C, Yuan Z. Precipitation and growth behaviour of metatitanic acid particles from titanium sulfate solution. Powder Technol. 2017;315:31–6. doi: 10.1016/j.powtec.2017.03.047. [DOI] [Google Scholar]
- 27.Tucci P, Porta G, Agostini M, Dinsdale D, Iavicoli I, Cain K, et al. Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes. Cell Death Dis. 2013;4:e549. doi: 10.1038/cddis.2013.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Jafari S, Mahyad B, Hashemzadeh H, Janfaza S, Gholikhani T, Tayebi L. Biomedical applications of TiO2 nanostructures: recent advances. Int J Nanomed. 2020;15:3447. doi: 10.2147/IJN.S249441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ghanbary F, Seydi E, Naserzadeh P, Salimi A. Toxicity of nanotitanium dioxide (TiO2-NP) on human monocytes and their mitochondria. Environ Sci Pollut Res. 2018;25:6739–50. doi: 10.1007/s11356-017-0974-2. [DOI] [PubMed] [Google Scholar]
- 30.Cai Z, Zhang J, Li H. Selenium, aging and aging-related diseases. Aging Clin Exp Res. 2019;31:1035–47. doi: 10.1007/s40520-018-1086-7. [DOI] [PubMed] [Google Scholar]
- 31.de Keizer PL, Laberge R-M, Campisi J. p53: pro-aging or pro-longevity? Aging. 2010;2:377. doi: 10.18632/aging.100178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kenyon CJ. The genetics of ageing. Nature. 2010;464:504–12. doi: 10.1038/nature08980. [DOI] [PubMed] [Google Scholar]
- 33.Panahi M, Rahimi B, Rahimi G, Yew Low T, Saraygord-Afshari N, Alizadeh E. Cytoprotective effects of antioxidant supplementation on mesenchymal stem cell therapy. J Cell Physiol. 2020;235:6462–95. doi: 10.1002/jcp.29660. [DOI] [PubMed] [Google Scholar]
- 34.Tilstra JS, Clauson CL, Niedernhofer LJ, Robbins PD. NF-κB in aging and disease. Aging Dis. 2011;2:449. [PMC free article] [PubMed] [Google Scholar]
- 35.Salminen A, Kaarniranta K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-κB signaling. Cell Signal. 2010;22:573–7. doi: 10.1016/j.cellsig.2009.10.006. [DOI] [PubMed] [Google Scholar]
- 36.Han J, Mistriotis P, Lei P, Wang D, Liu S, Andreadis ST. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells. 2012;30:2746–59. doi: 10.1002/stem.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Münst B, Thier MC, Winnemöller D, Helfen M, Thummer RP, Edenhofer F. Nanog induces suppression of senescence via down-regulation of p27KIP1 expression. 2016. [DOI] [PMC free article] [PubMed]
- 38.Do JT, Schöler HR. Regulatory circuits underlying pluripotency and reprogramming. Trends Pharmacol Sci. 2009;30:296–302. doi: 10.1016/j.tips.2009.03.003. [DOI] [PubMed] [Google Scholar]
- 39.Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122:947–56. doi: 10.1016/j.cell.2005.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Law IK, Liu L, Xu A, Lam KS, Vanhoutte PM, Che CM, et al. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti‐aging and metabolic effects of sirtuins. Proteomics. 2009;9:2444–56. doi: 10.1002/pmic.200800738. [DOI] [PubMed] [Google Scholar]
- 41.Sedding D, Haendeler J. Do we age on Sirt1 expression? Circ Res. 2007;100:1396–8. doi: 10.1161/01.RES.0000269326.37165.3d. [DOI] [PubMed] [Google Scholar]
- 42.Guarente L, Picard F. Calorie restriction—the SIR2 connection. Cell. 2005;120:473–82. doi: 10.1016/j.cell.2005.01.029. [DOI] [PubMed] [Google Scholar]
- 43.Hong J, Zhang Y-Q. Murine liver damage caused by exposure to nano-titanium dioxide. Nanotechnology. 2016;27:112001. doi: 10.1088/0957-4484/27/11/112001. [DOI] [PubMed] [Google Scholar]
- 44.Schanen BC, Karakoti AS, Seal S, Drake DR, III, Warren WL, Self WT. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. Acs Nano. 2009;3:2523–32. doi: 10.1021/nn900403h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol. 2005;6:587. doi: 10.1038/ni1200. [DOI] [PubMed] [Google Scholar]
- 46.Kansara K, Patel P, Shah D, Shukla RK, Singh S, Kumar A, et al. TiO2 nanoparticles induce DNA double strand breaks and cell cycle arrest in human alveolar cells. Environ Mol Mutagenesis. 2015;56:204–17. doi: 10.1002/em.21925. [DOI] [PubMed] [Google Scholar]
- 47.Hou Y, Cai K, Li J, Chen X, Lai M, Hu Y, et al. Effects of titanium nanoparticles on adhesion, migration, proliferation, and differentiation of mesenchymal stem cells. Int J Nanomed. 2013;8:3619. doi: 10.2147/IJN.S38992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Bennat C, Müller-Goymann C. Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter. Int J Cosmet Sci. 2000;22:271–83. doi: 10.1046/j.1467-2494.2000.00009.x. [DOI] [PubMed] [Google Scholar]
- 49.Gao G, Ze Y, Zhao X, Sang X, Zheng L, Ze X, et al. Titanium dioxide nanoparticle-induced testicular damage, spermatogenesis suppression, and gene expression alterations in male mice. J Hazard Mater. 2013;258:133–43. doi: 10.1016/j.jhazmat.2013.04.046. [DOI] [PubMed] [Google Scholar]
- 50.Wamer WG, Yin J-J, Wei RR. Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med. 1997;23:851–8. doi: 10.1016/S0891-5849(97)00068-3. [DOI] [PubMed] [Google Scholar]
- 51.Chen J, Dong X, Zhao J, Tang G. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol. 2009;29:330–7. doi: 10.1002/jat.1414. [DOI] [PubMed] [Google Scholar]